RALEIGH, N.C.--(BUSINESS WIRE)--Ajinomoto AminoScience LLC (AAS) today announced the availability of a case study profiling how one global pharmaceutical company relied on its CorynexTM Recombinant Protein Expression System to express and purify proteins. This new case study further builds upon Ajinomoto’s proven success expressing complex proteins with the CorynexTM Expression System.
